| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1529 | 2010 |
| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 558 | 2017 |
| Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement … H Amital, Z Szekanecz, G Szücs, K Danko, E Nagy, T Csepany, E Kiss, ... Annals of the rheumatic diseases 69 (6), 1155-1157, 2010 | 399 | 2010 |
| Novel biomarkers in autoimmune diseases H Orbach, G ZANDMAN‐GODDARD, H AMITAL, V Barak, Z Szekanecz, ... Annals of the New York Academy of Sciences 1109 (1), 385-400, 2007 | 337 | 2007 |
| EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis HW van Steenbergen, D Aletaha, LJJ Beaart-van de Voorde, E Brouwer, ... Annals of the rheumatic diseases 76 (3), 491-496, 2017 | 315 | 2017 |
| Association of systemic and thyroid autoimmune diseases E Biró, Z Szekanecz, K Dankó, E Kiss, NA Szabó, G Szűcs, M Zeher, ... Clinical rheumatology 25, 240-245, 2006 | 283 | 2006 |
| Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. P Szodoray, Z Szabó, A Kapitány, A Gyetvai, G Lakos, S Szántó, G Szücs, ... Autoimmunity reviews 9 (3), 140, 2010 | 266 | 2010 |
| Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ... Arthritis & rheumatology 69 (2), 362-375, 2017 | 232 | 2017 |
| Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD) E Bodolay, Z Csiki, Z Szekanecz, T Ben, E Kiss, M Zeher, G Szücs, ... Clinical and experimental rheumatology 21 (3), 313-320, 2003 | 216 | 2003 |
| Accelerated atherosclerosis in rheumatoid arthritis Z SZEKANECZ, G KEREKES, H DÉR, Z SÁNDOR, Z SZABÓ, A VÉGVÁRI, ... Annals of the New York Academy of Sciences 1108 (1), 349-358, 2007 | 196 | 2007 |
| Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature Y Arnson, H Amital, N Agmon-Levin, D Alon, M Sánchez-Castañón, ... Autoimmunity reviews 10 (8), 490-494, 2011 | 190 | 2011 |
| Digital ulcers predict a worse disease course in patients with systemic sclerosis C Mihai, R Landewé, D Van Der Heijde, UA Walker, PI Constantin, ... Annals of the rheumatic diseases 75 (4), 681-686, 2016 | 181 | 2016 |
| Survival and causes of death in 366 Hungarian patients with systemic sclerosis L Czirják, G Kumánovics, C Varjú, Z Nagy, A Pákozdi, Z Szekanecz, ... Annals of the rheumatic diseases 67 (1), 59-63, 2008 | 179 | 2008 |
| Endothelial dysfunction precedes atherosclerosis in systemic sclerosis—relevance for prevention of vascular complications G Szucs, O Timar, Z Szekanecz, H Dér, G Kerekes, S Szamosi, ... Rheumatology, 2007 | 179 | 2007 |
| Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study J Avouac, UA Walker, E Hachulla, G Riemekasten, G Cuomo, PE Carreira, ... Annals of the rheumatic diseases 75 (1), 103-109, 2016 | 157 | 2016 |
| Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment P Soltész, G Kerekes, H Dér, G Szücs, S Szántó, E Kiss, E Bodolay, ... Autoimmunity Reviews 10 (7), 416-425, 2011 | 152 | 2011 |
| A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic … P Soltész, H Dér, G Kerekes, P Szodoray, G Szücs, K Dankó, Y Shoenfeld, ... Clinical rheumatology 28 (6), 655-662, 2009 | 151 | 2009 |
| Rho‐associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts A Akhmetshina, C Dees, M Pileckyte, G Szucs, BM Spriewald, J Zwerina, ... Arthritis & Rheumatism 58 (8), 2553-2564, 2008 | 149 | 2008 |
| Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases Z Szekanecz, IB McInnes, G Schett, S Szamosi, S Benkő, G Szűcs Nature Reviews Rheumatology 17 (10), 585-595, 2021 | 148 | 2021 |
| Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system E Szalai, A Berta, Z Szekanecz, G Szûcs, L Módis Jr Cornea 31 (8), 867-871, 2012 | 144 | 2012 |
Zoltán SzekaneczProfessor of Rheumatology, Immunology and Medicine, University of Debrecen Faculty of Medicine在 med.unideb.hu 的电子邮件经过验证
